Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME 12:35:07 2024-03-18 pm EDT 5-day change 1st Jan Change
7.488 EUR -0.56% Intraday chart for Grifols, S.A. -11.74% -51.55%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading MT
Sector Update: Health Care Stocks Retreating Late Afternoon MT
Grifols Downgraded by Fitch, S&P on Lower Cash Flows -- Shares Fall MT
Fitch Downgrades Grifols on Deleveraging Woes, Refinancing Risks MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
Shares in Spanish drugmaker Grifols tumble on Fitch, S&P downgrades RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading MT
US Futures, European Stocks Fall Ahead of U.S. Inflation Data DJ
ADRs Close Lower, Lixiang Education Holding Co. Ltd. Declines 19.6% DJ
European Equities Traded in the US as American Depositary Receipts Decline Friday MT
European Midday Briefing : Investors Await U.S. Jobs Data DJ
U.S. Futures, European Stocks Mixed Ahead of U.S. Jobs Data DJ
Spain's Grifols publishes 2023 results with auditor's 'unqualified opinion' RE
Short Seller Gotham City Research Raises Fresh Challenge Against Grifols' Integrity, Ethical Conduct MT
Grifols shares drop to 12-year low after new Gotham City Research report RE
Sector Update: Health Care Stocks Edge Higher Premarket Wednesday MT
Sector Update: Health Care MT
Grifols: under Moody's watch, the share price plunges CF
Grifols Shares Fall Pre-Bell After New Research Note by Short Seller Gotham City MT
Grifols shares drop 15% after new Gotham City Research report RE
US Futures, European Stocks Edge Up DJ
Moody's to Review Grifols' Ratings for Potential Downgrade MT
European Equities Traded in the US as American Depositary Receipts Decline Tuesday MT
European Equities Traded in the US as American Depositary Receipts Rise Monday Afternoon MT
Chart Grifols, S.A.
More charts
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (77.3%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (14.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (5.4%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.3%), European Union (11.7%), the United States and Canada (63.6%) and other (19.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7.488 EUR
Average target price
18.86 EUR
Spread / Average Target
+151.83%
Consensus
  1. Stock
  2. Equities
  3. Stock Grifols, S.A. - BME
  4. News Grifols, S.A.
  5. Grifols S A : European ADRs Down Nearly 2% Friday as Mining, Steel Shares Drop